Antibodies that specifically bind CLDN6 or CD3 and bispecific antibodies that specifically bind CLDN6 and CD3
TW202635722APending Publication Date: 2026-09-01THIRD ARC BIO INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114139730
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-21
- Filing Date
- 2025-10-15
- Publication Date
- 2026-09-01
Smart Images
Figure TWG2TA001074378_001 
Figure TWG2TA001074378_002 
Figure TWG2TA001074378_003
Abstract
Antibodies and antigen-binding fragments thereof that specifically bind CLDN6 or CD3, and bispecific antibodies and antigen-binding domains that specifically bind CLDN6 and CD3 are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer.
Need to check novelty before this filing date? Find Prior Art